Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.28.534561Source: DataRank Database

Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancer is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0.104. It has been cited 1 time.

N/A

0.104DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)OA: greenTopics (29)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.104

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (11)

Timothy H.-P. Chen,Bryan Fisk ORCID,Haolin Shen ORCID,Matthew Mosior ORCID,Zachary L. Skidmore ORCID

Live enrichment

PubMed:37034778 OpenAlex:https://openalex.org/W4361228324

National Institutes of Health

Grant: 5U01CA248235-03

Informatics tools for identification, prioritization and clinical application of neoantigens

National Institutes of Health

Grant: 1U01CA231844-01

Genomic and Functional Identification of Chemotherapy Resistance Mechanisms in Small Cell Lung Cancer

National Institutes of Health

Grant: 1U24CA237719-01

Standardized and Genome-Wide Clinical Interpretation of Complex Genotypes for Cancer Precision Medicine

National Institutes of Health

Grant: 4R00HG007940-03

Integrated Analysis & Interpretation of Whole Genome Exome & Transcriptome Sequen

National Institutes of Health

Grant: 5U01CA209936-03

DEVELOPMENT OF INFORMATICS RESOURCES FOR INTERPRETATION OF CLINICALLY ACTIONABLE VARIANTS IN CANCER

NCI NIH HHS

Grant: U01 CA248235

NCI NIH HHS

Grant: U01 CA209936

NCI NIH HHS

Grant: U01 CA231844

NHGRI NIH HHS

Grant: R00 HG007940

NCI NIH HHS

Grant: U24 CA237719

greenLicense: cc-by

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2023/03/29/2023.03.28.534561.full.pdf

GREENhttps://doi.org/10.1016/j.isci.2023.107937

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2023/03/29/2023.03.28.534561.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2023.03.28.534561

repositoryhttps://doi.org/10.1101/2023.03.28.534561

Fields of Study

Bladder and Urothelial Cancer TreatmentsCancer Immunotherapy and BiomarkersImmune cells in cancerMedicineBiology03 medical and health sciences0302 clinical medicine

Keywords

Cancer researchImmune checkpointBladder cancerDownregulation and upregulationBlockadeImmune systemBiologySomatic cellCellCancerImmunotherapyGeneImmunologyReceptorBiochemistryOncologyScienceQICTS (Institute of Clinical and Translational Sciences)Medicine and Health SciencesTranscriptomicsArticle

Sustainable Development Goals

SDG 0: Good health and well-being